Glaxo Sued in the U.K. Over Avandia Diabetes Drug Health Risks

GlaxoSmithKline Plc faces at least four U.K. lawsuits over its Avandia diabetes drug amid claims it’s linked to an increased risk of heart attacks and congestive heart failure.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.